Nasdaq: BLSM
BlossomHill Therapeutics insiders
The officers, directors and 10% owners of BlossomHill Therapeutics, Inc. who hold the most stock, valued at the live BLSM price.
$14.41
BLSM today −$180K (−1.23%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their BLSM stock
- $65.7M
- Market value
- $458M
- Held by ranked insiders
- 14.3%
Insiders by value of BLSM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Yishan Li | Executive Chairman | 1,986,569 | $28.6M | 6.25% | 3930th |
| 2 | Jingrong Jean Cui | President and CEO | 1,986,569 | $28.6M | 6.25% | 3931st |
| 3 | Sundeep Agrawal | Director | 578,524 | $8.3M | 1.82% | 10051st |
| 4 | John P. Schmid | Director | 6,000 | $86K | <0.1% | 11065th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BlossomHill Therapeutics; see each profile for the filing.